![Sushanta Mallick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sushanta Mallick worked as Vice President-Research & Development at QLT, Inc. and as Head-Clinical Trial Management at ESBATech AG.
Mallick holds an MBA degree from The University of Texas at Austin and a doctorate degree from the University of North Texas.
| Sociétés | Poste | Fin |
|---|---|---|
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Directeur Technique/Scientifique/R&D | - |
ESBATech, a Novartis Co. GmbH
 ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services Develops antibody fragment therapeutics | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of North Texas
 University of North Texas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESBATech, a Novartis Co. GmbH
ESBATech, a Novartis Co. GmbH Miscellaneous Commercial ServicesCommercial Services Develops antibody fragment therapeutics | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
